Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Receivables - Other (2016 - 2025)

Altimmune (ALT) has disclosed Receivables - Other for 11 consecutive years, with $700000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Other rose 133.33% to $700000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $700000.0, a 133.33% increase, with the full-year FY2024 number at $400000.0, up 300.0% from a year prior.
  • Receivables - Other was $700000.0 for Q3 2025 at Altimmune, up from $400000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $700000.0 in Q3 2025 to a low of $100000.0 in Q4 2023.
  • A 3-year average of $342857.1 and a median of $300000.0 in 2024 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: soared 300.0% in 2024, then skyrocketed 100.0% in 2025.
  • Altimmune's Receivables - Other stood at $100000.0 in 2023, then skyrocketed by 300.0% to $400000.0 in 2024, then skyrocketed by 75.0% to $700000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Receivables - Other are $700000.0 (Q3 2025), $400000.0 (Q1 2025), and $400000.0 (Q4 2024).